|
2025
|
G/S
|
Marketing research or analysis; marketing research or analysis relating to pharmaceuticals; marke... |
|
|
G/S
|
Marketing research or analysis; marketing research or
analysis relating to pharmaceuticals; mark... |
|
2023
|
Invention
|
Imidazole derivative. The present invention relates to a compound represented by general formula ... |
|
2022
|
Invention
|
Antisense oligonucleotide derivative for atn1. As an antisense oligonucleotide derivative that ca... |
|
|
Invention
|
Medicine comprising glycopyrronium salicylate.
A medicine includes glycopyrronium salicylate or ... |
|
|
Invention
|
Pharmaceutical comprising glycopyrronium-salicylate. The present invention pertains to a pharmace... |
|
2021
|
Invention
|
Antisense oligonucleotide of atn1.
The invention provides an antisense oligonucleotide capable o... |
|
|
Invention
|
Antisense oligonucleotide of atn1. Provided is an antisense oligonucleotide that controls the gen... |
|
2020
|
Invention
|
Method for producing benzazepine derivative and intermediate of same. The present application dis... |
|
|
Invention
|
Benzazepine derivative alcoholate or crystal thereof. This invention provides an alcoholate of (S... |
|
2018
|
Invention
|
Immunochromatography device. A test strip including: a first site that's a detection site, where ... |
|
|
Invention
|
Immunochromatography device. The present invention relates to a test strip comprising: (1) a firs... |
|
|
Invention
|
Medicine for treating advanced or recurrent cancer patient being non-responsive or non-tolerant t... |
|
|
Invention
|
Therapeutic agent for alcohol use disorders. The present invention addresses the problem of provi... |
|
2016
|
Invention
|
Crystal of salt of novel 3-azabicyclo[3.1.0]hexane derivative and pharmaceutical use thereof. The... |
|
|
Invention
|
Drug for preventing or treating cardiac failure. The purpose of the present invention is to provi... |
|
2015
|
Invention
|
Production method for 5,7-unsubstituted-pyrazolo[1,5-a]pyrimidine-6-carboxylic acid. Provided is ... |
|
2014
|
Invention
|
Novel 3-azabicyclo[3.1.0]hexane derivative and use thereof for medical purposes. The present inve... |
|
|
Invention
|
Medicine for preventing or suppressing survival of cancer cells and having organic acid polymer a... |
|
|
Invention
|
Pharmaceutical preparation. Provided is a pharmaceutical preparation which comprises a DPP-IV inh... |
|
|
Invention
|
Orally disintegrating tablet.
Disclosed is an orally disintegrating tablet including: (a) an act... |
|
|
Invention
|
Orally disintegrating tablet. Disclosed is an orally disintegrating tablet which comprises (a) an... |
|
|
Invention
|
Crystal of (2s,4s)-6-fluoro-2',5'-dioxospiro[chromane-4,4'- imidazolidine]-2-carboxamide. A cryst... |
|
2013
|
Invention
|
Benzoazepine derivative and medical use thereof. A compound having a V2 receptor agonistic activi... |
|
|
Invention
|
Novel benzazepine derivative and pharmaceutical use thereof. The objective of the present inventi... |
|
|
Invention
|
Anagliptin-containing solid pharmaceutical preparation. Provided is a solid pharmaceutical prepar... |
|
|
Invention
|
Anagliptin-containing preparation. The objectives of the present invention are to provide: an ana... |
|
|
Invention
|
Anagliptin-containing solid preparation. Provided is a solid preparation containing anagliptin an... |
|
|
Invention
|
Anagliptin-containing drug composition. Provided is a drug composition containing anagliptin and ... |
|
|
Invention
|
Drug for preventing or treating dyslipidemia. The present invention addresses the problem of prov... |
|
|
Invention
|
Crystal of n-[2-(amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide.
An obje... |
|
|
Invention
|
Crystal of n-[2-({2-[(2s)-2-cyanopyrrolidin-1-yl]-2- oxoethyl}amino)-2-methylpropyl]-2-methylpyra... |
|
|
Invention
|
Pharmaceutical for preventing or treating gingivitis. [Problem] The present invention addresses t... |
|
2012
|
Invention
|
Powder filling device with redundant powder collection mechanism, and rotary compression molding ... |
|
|
Invention
|
Pharmaceutical preparation containing polystyrenesulfonic acid salt. [Problem] To provide a pharm... |
|
|
Invention
|
Analysis method.
In a method for detecting a glucagon-secretin family peptide in a sample, the s... |
|
|
Invention
|
Analysis method. Provided is a method for analyzing glucagon-secretin family peptides, the method... |
|
|
Invention
|
Medicinal agent for prevention or treatment of diseases associated with intraocular neovasculariz... |
|
|
Invention
|
Coated preparation containing azosemide as active ingredient. [Problem] To provide a preparation ... |
|
2011
|
Invention
|
Medicine for preventing and treating renal dysfunction. Provided is a medicine for preventing and... |
|
|
Invention
|
Novel thiophenecarboxamide derivatives and use thereof as medicine. Provided are compounds that h... |
|
|
Invention
|
Peptide for improving biostability of bioactive substance, and bioactive substance having improve... |
|
|
Invention
|
Peptide for improving in vivo stability of physiologically active substance or the like and physi... |
|
|
Invention
|
Pharmaceutical for preventing or treating an inner ear disorder.
A pharmaceutical for preventing... |
|
|
Invention
|
Prophylactic or therapeutic medication for inner ear disorders. Disclosed is a medication for the... |
|
|
Invention
|
Agent for preventing or treating crohn's disease, comprising organic acid polymer.
The present i... |
|
|
Invention
|
Prophylactic or therapeutic agent for crohn's disease comprising organic acid polymer as active i... |
|
|
Invention
|
Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or ele... |
|
2010
|
Invention
|
Novel thiophenecarboxamide derivative and pharmaceutical use thereof.
The object of the present ... |
|
2007
|
G/S
|
Producing for others compression moulded, dry-coated tablets containing pharmaceuticals of any ty... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of the central nervous system, namely, central nerv... |
|
|
G/S
|
Compression moulded pharmaceutical preparations;
pharmaceutical agents affecting central nervous... |
|
|
G/S
|
Processing machines and their parts for molding powdery pharmaceutical preparations into the form... |
|
|
G/S
|
Compression moulded pharmaceutical preparations;
pharmaceutical agents affecting the central ner... |
